Interestingly, it was observed that CD36 expression on SMCs is upregulated in diabetic patients, triggered by hyperglycemia condition and oxLDL exposure, leading to increased cholesterol influx and SMC foam cell development (Xue et al., 2010; Navas-Madroñal et al., 2020). This evidence concerns the gene CD36 and Hyperglycemia.